Budkevich L I, Mirzoyan G V, Gabitov R B, Brazol M A, Salistyj P V, Chikinev Y V, Shmyrin A A, Glutkin A V
Professor, Chief Researcher, Department of Combustiology and Reconstructive Plastic Surgery, Research Institute of Pediatric Surgery, Pirogov Russian National Research Medical University, 1 Ostrovitianova St., Moscow, 117997, Russia; Head of the Burn Center, Children's City Clinical Hospital No.9 named after G.N. Speransky, 29 Shmitovskiy Proezd, Moscow, 123317, Russia; Head of the 2 Burn Unit, Children's City Clinical Hospital No.9 named after G.N. Speransky, 29 Shmitovskiy Proezd, Moscow, 123317, Russia.
Pediatric Surgeon, the 2 Burn Unit, Children's City Clinical Hospital No.9 named after G.N. Speransky, 29 Shmitovskiy Proezd, Moscow, 123317, Russia.
Sovrem Tekhnologii Med. 2020;12(1):92-96. doi: 10.17691/stm2020.12.1.12.
was to evaluate the efficacy and safety of the Collost bioplastic material in the treatment of borderline and mosaic burns.
We conducted a prospective multicenter study, which included 94 patients aged 1 to 12 years with thermal skin burns (grade II-III by ICD-10). Patients were divided into four groups. In groups 1-3, various forms of the Collost bioplastic material were used (group 1 - 7% gel, group 2 - membranes, group 3 - powder) in combination with hydrocolloid dressings containing Ag ions. Patients of the control group (group 4) underwent the traditional local conservative treatment using hydrocolloid dressings alone. Concomitant therapy was similar in all of the participating centers. The total follow-up period was 4 weeks from the date of burn injury.
On day 14, there were 23 cases (92%) of complete epithelization in group 1, 13 cases (68.4%) - in group 2, 21 cases (78%) - in group 3, and 9 cases (39.1%) - in group 4. The data from groups 1 and 3 significantly differed from those in control (p<0.05). The epithelialization of the burned skin in the Collost groups (7% gel and powder) was on average one week faster compared to the control.
The Collost bioplastic material (in the form of gel or powder) in combination with hydrocolloid dressings can be a functional and inexpensive alternative to autografts in the treatment of borderline and mosaic burns.
旨在评估Collost生物塑料材料治疗临界性和镶嵌性烧伤的疗效和安全性。
我们进行了一项前瞻性多中心研究,纳入94例1至12岁的皮肤热烧伤患者(根据ICD - 10为II - III级)。患者分为四组。在第1 - 3组中,使用了各种形式的Collost生物塑料材料(第1组 - 7%凝胶,第2组 - 膜,第3组 - 粉末),并与含银离子的水胶体敷料联合使用。对照组(第4组)患者仅使用水胶体敷料进行传统的局部保守治疗。所有参与中心的伴随治疗相似。从烧伤日期起的总随访期为4周。
在第14天,第1组有23例(92%)完全上皮化,第2组有13例(68.4%),第3组有21例(78%),第4组有9例(39.1%)。第1组和第3组的数据与对照组有显著差异(p<0.05)。与对照组相比,Collost组(7%凝胶和粉末)烧伤皮肤的上皮化平均快一周。
Collost生物塑料材料(凝胶或粉末形式)与水胶体敷料联合使用,在治疗临界性和镶嵌性烧伤方面,可成为自体移植的一种有效且廉价的替代方法。